><title>References</title><ref id="ppat.1002607-Ottenhoff1"><label>1</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ottenhoff</surname><given-names>TH</given-names></name></person-group>
<year>2009</year>
<article-title>Overcoming the global crisis: &#x0201c;yes, we can", but also for TB &#x02026; ?</article-title>
<source>Eur J Immunol</source>
<volume>39</volume>
<fpage>2014</fpage>
<lpage>2020</lpage>
<pub-id pub-id-type="pmid">19672895</pub-id></element-citation></ref><ref id="ppat.1002607-Kaufmann1"><label>2</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>SH</given-names></name><name><surname>Winau</surname><given-names>F</given-names></name></person-group>
<year>2005</year>
<article-title>From bacteriology to immunology: the dualism of specificity.</article-title>
<source>Nat Immunol</source>
<volume>6</volume>
<fpage>1063</fpage>
<lpage>1066</lpage>
<pub-id pub-id-type="pmid">16239917</pub-id></element-citation></ref><ref id="ppat.1002607-Kaufmann2"><label>3</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>SH</given-names></name><name><surname>Hussey</surname><given-names>G</given-names></name><name><surname>Lambert</surname><given-names>PH</given-names></name></person-group>
<year>2010</year>
<article-title>New vaccines for tuberculosis.</article-title>
<source>Lancet</source>
<volume>375</volume>
<fpage>2110</fpage>
<lpage>2119</lpage>
<pub-id pub-id-type="pmid">20488515</pub-id></element-citation></ref><ref id="ppat.1002607-WHO1"><label>4</label><element-citation publication-type="other">
<collab>WHO</collab>
<year>2009</year>
<comment>Global tuberculosis control: epidemiology, strategy, financing, WHO report 2009</comment>
</element-citation></ref><ref id="ppat.1002607-Gandhi1"><label>5</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gandhi</surname><given-names>NR</given-names></name><name><surname>Nunn</surname><given-names>P</given-names></name><name><surname>Dheda</surname><given-names>K</given-names></name><name><surname>Schaaf</surname><given-names>HS</given-names></name><name><surname>Zignol</surname><given-names>M</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis.</article-title>
<source>Lancet</source>
<volume>375</volume>
<fpage>1830</fpage>
<lpage>1843</lpage>
<pub-id pub-id-type="pmid">20488523</pub-id></element-citation></ref><ref id="ppat.1002607-Velayati1"><label>6</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Velayati</surname><given-names>AA</given-names></name><name><surname>Masjedi</surname><given-names>MR</given-names></name><name><surname>Farnia</surname><given-names>P</given-names></name><name><surname>Tabarsi</surname><given-names>P</given-names></name><name><surname>Ghanavi</surname><given-names>J</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran.</article-title>
<source>Chest</source>
<volume>136</volume>
<fpage>420</fpage>
<lpage>425</lpage>
<pub-id pub-id-type="pmid">19349380</pub-id></element-citation></ref><ref id="ppat.1002607-Calmette1"><label>7</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Calmette</surname><given-names>A</given-names></name><name><surname>Gu&#x000e9;rin</surname><given-names>C</given-names></name><name><surname>Boquet</surname><given-names>A</given-names></name><name><surname>N&#x000e9;gre</surname><given-names>L</given-names></name></person-group>
<year>1927</year>
<article-title>La vaccination pr&#x000e9;ventive contre la tuberculose par le &#x0201c;BCG".</article-title>
<source>Masson</source>
</element-citation></ref><ref id="ppat.1002607-Waksman1"><label>8</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Waksman</surname><given-names>SA</given-names></name></person-group>
<year>1964</year>
<source>The conquest of tuberculosis</source>
<publisher-name>University of California Press</publisher-name>
</element-citation></ref><ref id="ppat.1002607-Kaufmann3"><label>9</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>SH</given-names></name><name><surname>Parida</surname><given-names>SK</given-names></name></person-group>
<year>2007</year>
<article-title>Changing funding patterns in tuberculosis.</article-title>
<source>Nat Med</source>
<volume>13</volume>
<fpage>299</fpage>
<lpage>303</lpage>
<pub-id pub-id-type="pmid">17342144</pub-id></element-citation></ref><ref id="ppat.1002607-Cole1"><label>10</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cole</surname><given-names>ST</given-names></name><name><surname>Brosch</surname><given-names>R</given-names></name><name><surname>Parkhill</surname><given-names>J</given-names></name><name><surname>Garnier</surname><given-names>T</given-names></name><name><surname>Churcher</surname><given-names>C</given-names></name><etal/></person-group>
<year>1998</year>
<article-title>Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.</article-title>
<source>Nature</source>
<volume>393</volume>
<fpage>537</fpage>
<lpage>544</lpage>
<pub-id pub-id-type="pmid">9634230</pub-id></element-citation></ref><ref id="ppat.1002607-Aronson1"><label>11</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aronson</surname><given-names>NE</given-names></name><name><surname>Santosham</surname><given-names>M</given-names></name><name><surname>Comstock</surname><given-names>GW</given-names></name><name><surname>Howard</surname><given-names>RS</given-names></name><name><surname>Moulton</surname><given-names>LH</given-names></name><etal/></person-group>
<year>2004</year>
<article-title>Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: a 60-year follow-up study.</article-title>
<source>JAMA</source>
<volume>291</volume>
<fpage>2086</fpage>
<lpage>2091</lpage>
<pub-id pub-id-type="pmid">15126436</pub-id></element-citation></ref><ref id="ppat.1002607-Hesseling1"><label>12</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hesseling</surname><given-names>AC</given-names></name><name><surname>Marais</surname><given-names>BJ</given-names></name><name><surname>Gie</surname><given-names>RP</given-names></name><name><surname>Schaaf</surname><given-names>HS</given-names></name><name><surname>Fine</surname><given-names>PE</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.</article-title>
<source>Vaccine</source>
<volume>25</volume>
<fpage>14</fpage>
<lpage>18</lpage>
<pub-id pub-id-type="pmid">16959383</pub-id></element-citation></ref><ref id="ppat.1002607-Ottenhoff2"><label>13</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ottenhoff</surname><given-names>TH</given-names></name><name><surname>Verreck</surname><given-names>FA</given-names></name><name><surname>Lichtenauer-Kaligis</surname><given-names>EG</given-names></name><name><surname>Hoeve</surname><given-names>MA</given-names></name><name><surname>Sanal</surname><given-names>O</given-names></name><etal/></person-group>
<year>2002</year>
<article-title>Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae.</article-title>
<source>Nat Genet</source>
<volume>32</volume>
<fpage>97</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="pmid">12205477</pub-id></element-citation></ref><ref id="ppat.1002607-Vosse1"><label>14</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vosse</surname><given-names>Evd</given-names></name><name><surname>Hoeve</surname><given-names>MA</given-names></name><name><surname>Ottenhoff</surname><given-names>TH</given-names></name></person-group>
<year>2004</year>
<article-title>Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae.</article-title>
<source>Lancet Infect Dis</source>
<volume>4</volume>
<fpage>739</fpage>
<lpage>749</lpage>
<pub-id pub-id-type="pmid">15567123</pub-id></element-citation></ref><ref id="ppat.1002607-Weir1"><label>15</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weir</surname><given-names>RE</given-names></name><name><surname>Black</surname><given-names>GF</given-names></name><name><surname>Nazareth</surname><given-names>B</given-names></name><name><surname>Floyd</surname><given-names>S</given-names></name><name><surname>Stenson</surname><given-names>S</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Guerin vaccination in southern England and northern Malawi.</article-title>
<source>Clin Exp Immunol</source>
<volume>146</volume>
<fpage>390</fpage>
<lpage>399</lpage>
<pub-id pub-id-type="pmid">17100757</pub-id></element-citation></ref><ref id="ppat.1002607-Barry1"><label>16</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barry</surname><given-names>CE</given-names><suffix>III</suffix></name><name><surname>Boshoff</surname><given-names>HI</given-names></name><name><surname>Dartois</surname><given-names>V</given-names></name><name><surname>Dick</surname><given-names>T</given-names></name><name><surname>Ehrt</surname><given-names>S</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>The spectrum of latent tuberculosis: rethinking the biology and intervention strategies.</article-title>
<source>Nat Rev Microbiol</source>
<volume>7</volume>
<fpage>845</fpage>
<lpage>855</lpage>
<pub-id pub-id-type="pmid">19855401</pub-id></element-citation></ref><ref id="ppat.1002607-Cobat1"><label>17</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cobat</surname><given-names>A</given-names></name><name><surname>Gallant</surname><given-names>CJ</given-names></name><name><surname>Simkin</surname><given-names>L</given-names></name><name><surname>Black</surname><given-names>GF</given-names></name><name><surname>Stanley</surname><given-names>K</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Two loci control tuberculin skin test reactivity in an area hyperendemic for tuberculosis.</article-title>
<source>J Exp Med</source>
<volume>206</volume>
<fpage>2583</fpage>
<lpage>2591</lpage>
<pub-id pub-id-type="pmid">19901083</pub-id></element-citation></ref><ref id="ppat.1002607-Rose1"><label>18</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rose</surname><given-names>DN</given-names></name><name><surname>Schechter</surname><given-names>CB</given-names></name><name><surname>Adler</surname><given-names>JJ</given-names></name></person-group>
<year>1995</year>
<article-title>Interpretation of the tuberculin skin test.</article-title>
<source>J Gen Intern Med</source>
<volume>10</volume>
<fpage>635</fpage>
<lpage>642</lpage>
<pub-id pub-id-type="pmid">8583267</pub-id></element-citation></ref><ref id="ppat.1002607-Lillebaek1"><label>19</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lillebaek</surname><given-names>T</given-names></name><name><surname>Andersen</surname><given-names>AB</given-names></name><name><surname>Dirksen</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>E</given-names></name><name><surname>Skovgaard</surname><given-names>LT</given-names></name><etal/></person-group>
<year>2002</year>
<article-title>Persistent high incidence of tuberculosis in immigrants in a low-incidence country.</article-title>
<source>Emerg Infect Dis</source>
<volume>8</volume>
<fpage>679</fpage>
<lpage>684</lpage>
<pub-id pub-id-type="pmid">12095434</pub-id></element-citation></ref><ref id="ppat.1002607-Corbett1"><label>20</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Corbett</surname><given-names>EL</given-names></name><name><surname>Watt</surname><given-names>CJ</given-names></name><name><surname>Walker</surname><given-names>N</given-names></name><name><surname>Maher</surname><given-names>D</given-names></name><name><surname>Williams</surname><given-names>BG</given-names></name><etal/></person-group>
<year>2003</year>
<article-title>The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.</article-title>
<source>Arch Intern Med</source>
<volume>163</volume>
<fpage>1009</fpage>
<lpage>1021</lpage>
<pub-id pub-id-type="pmid">12742798</pub-id></element-citation></ref><ref id="ppat.1002607-Keane1"><label>21</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Keane</surname><given-names>J</given-names></name><name><surname>Gershon</surname><given-names>S</given-names></name><name><surname>Wise</surname><given-names>RP</given-names></name><name><surname>Mirabile-Levens</surname><given-names>E</given-names></name><name><surname>Kasznica</surname><given-names>J</given-names></name><etal/></person-group>
<year>2001</year>
<article-title>Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.</article-title>
<source>N Engl J Med</source>
<volume>345</volume>
<fpage>1098</fpage>
<lpage>104</lpage>
<pub-id pub-id-type="pmid">11596589</pub-id></element-citation></ref><ref id="ppat.1002607-Pai1"><label>22</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pai</surname><given-names>M</given-names></name><name><surname>Minion</surname><given-names>J</given-names></name><name><surname>Steingart</surname><given-names>K</given-names></name><name><surname>Ramsay</surname><given-names>A</given-names></name></person-group>
<year>2010</year>
<article-title>New and improved tuberculosis diagnostics: evidence, policy, practice, and impact.</article-title>
<source>Curr Opin Pulm Med</source>
<volume>16</volume>
<fpage>271</fpage>
<lpage>284</lpage>
<pub-id pub-id-type="pmid">20224410</pub-id></element-citation></ref><ref id="ppat.1002607-Parida1"><label>23</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Parida</surname><given-names>SK</given-names></name><name><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group>
<year>2010</year>
<article-title>The quest for biomarkers in tuberculosis.</article-title>
<source>Drug Discov Today</source>
<volume>15</volume>
<fpage>148</fpage>
<lpage>157</lpage>
<pub-id pub-id-type="pmid">19854295</pub-id></element-citation></ref><ref id="ppat.1002607-Mittrucker1"><label>24</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mittrucker</surname><given-names>HW</given-names></name><name><surname>Steinhoff</surname><given-names>U</given-names></name><name><surname>Kohler</surname><given-names>A</given-names></name><name><surname>Krause</surname><given-names>M</given-names></name><name><surname>Lazar</surname><given-names>D</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis.</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>104</volume>
<fpage>12434</fpage>
<lpage>12439</lpage>
<pub-id pub-id-type="pmid">17640915</pub-id></element-citation></ref><ref id="ppat.1002607-Kaufmann4"><label>25</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group>
<year>2010</year>
<article-title>Future vaccination strategies against tuberculosis: thinking outside the box.</article-title>
<source>Immunity</source>
<volume>33</volume>
<fpage>567</fpage>
<lpage>577</lpage>
<pub-id pub-id-type="pmid">21029966</pub-id></element-citation></ref><ref id="ppat.1002607-Stop1"><label>26</label><element-citation publication-type="other">
<collab>Stop TB Partnership Working Group on New TB Vaccines 2</collab>
<year>2010</year>
<article-title>The global plan to stop TB 2011&#x02013;2015.</article-title>
<comment>Stop TB Partnership</comment>
</element-citation></ref><ref id="ppat.1002607-Liang1"><label>27</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liang</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>Treatment of multi-drug-resistant tuberculosis in mice with DNA vaccines alone or in combination with chemotherapeutic drugs.</article-title>
<source>Scand J Immunol</source>
<volume>74</volume>
<fpage>42</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="pmid">21352251</pub-id></element-citation></ref><ref id="ppat.1002607-Andersen1"><label>28</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Andersen</surname><given-names>P</given-names></name><name><surname>Doherty</surname><given-names>TM</given-names></name></person-group>
<year>2005</year>
<article-title>The success and failure of BCG - implications for a novel tuberculosis vaccine.</article-title>
<source>Nat Rev Microbiol</source>
<volume>3</volume>
<fpage>656</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="pmid">16012514</pub-id></element-citation></ref><ref id="ppat.1002607-Hatherill1"><label>29</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hatherill</surname><given-names>M</given-names></name><name><surname>Adams</surname><given-names>V</given-names></name><name><surname>Hughes</surname><given-names>J</given-names></name><name><surname>de</surname><given-names>KM</given-names></name><name><surname>Mavakla</surname><given-names>W</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>The potential impact of helminth infection on trials of novel tuberculosis vaccines.</article-title>
<source>Vaccine</source>
<volume>27</volume>
<fpage>4743</fpage>
<lpage>4744</lpage>
<pub-id pub-id-type="pmid">19450634</pub-id></element-citation></ref><ref id="ppat.1002607-Potian1"><label>30</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Potian</surname><given-names>JA</given-names></name><name><surname>Rafi</surname><given-names>W</given-names></name><name><surname>Bhatt</surname><given-names>K</given-names></name><name><surname>McBride</surname><given-names>A</given-names></name><name><surname>Gause</surname><given-names>WC</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>Preexisting helminth infection induces inhibition of innate pulmonary anti-tuberculosis defense by engaging the IL-4 receptor pathway.</article-title>
<source>J Exp Med</source>
<volume>208</volume>
<fpage>1863</fpage>
<lpage>1874</lpage>
<pub-id pub-id-type="pmid">21825018</pub-id></element-citation></ref><ref id="ppat.1002607-Urdahl1"><label>31</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Urdahl</surname><given-names>KB</given-names></name><name><surname>Shafiani</surname><given-names>S</given-names></name><name><surname>Ernst</surname><given-names>JD</given-names></name></person-group>
<year>2011</year>
<article-title>Initiation and regulation of T-cell responses in tuberculosis.</article-title>
<source>Mucosal Immunol</source>
<volume>4</volume>
<fpage>288</fpage>
<lpage>293</lpage>
<pub-id pub-id-type="pmid">21451503</pub-id></element-citation></ref><ref id="ppat.1002607-Wolf1"><label>32</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wolf</surname><given-names>AJ</given-names></name><name><surname>Desvignes</surname><given-names>L</given-names></name><name><surname>Linas</surname><given-names>B</given-names></name><name><surname>Banaiee</surname><given-names>N</given-names></name><name><surname>Tamura</surname><given-names>T</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs.</article-title>
<source>J Exp Med</source>
<volume>205</volume>
<fpage>105</fpage>
<lpage>115</lpage>
<pub-id pub-id-type="pmid">18158321</pub-id></element-citation></ref><ref id="ppat.1002607-Reiley1"><label>33</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reiley</surname><given-names>WW</given-names></name><name><surname>Calayag</surname><given-names>MD</given-names></name><name><surname>Wittmer</surname><given-names>ST</given-names></name><name><surname>Huntington</surname><given-names>JL</given-names></name><name><surname>Pearl</surname><given-names>JE</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes.</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>105</volume>
<fpage>10961</fpage>
<lpage>10966</lpage>
<pub-id pub-id-type="pmid">18667699</pub-id></element-citation></ref><ref id="ppat.1002607-Gallegos1"><label>34</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gallegos</surname><given-names>AM</given-names></name><name><surname>Pamer</surname><given-names>EG</given-names></name><name><surname>Glickman</surname><given-names>MS</given-names></name></person-group>
<year>2008</year>
<article-title>Delayed protection by ESAT-6-specific effector CD4&#x0002b; T cells after airborne M. tuberculosis infection.</article-title>
<source>J Exp Med</source>
<volume>205</volume>
<fpage>2359</fpage>
<lpage>2368</lpage>
<pub-id pub-id-type="pmid">18779346</pub-id></element-citation></ref><ref id="ppat.1002607-Ulrichs1"><label>35</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ulrichs</surname><given-names>T</given-names></name><name><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group>
<year>2006</year>
<article-title>New insights into the function of granulomas in human tuberculosis.</article-title>
<source>J Pathol</source>
<volume>208</volume>
<fpage>261</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="pmid">16362982</pub-id></element-citation></ref><ref id="ppat.1002607-Day1"><label>36</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Day</surname><given-names>TA</given-names></name><name><surname>Koch</surname><given-names>M</given-names></name><name><surname>Nouailles</surname><given-names>G</given-names></name><name><surname>Jacobsen</surname><given-names>M</given-names></name><name><surname>Kosmiadi</surname><given-names>GA</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>Secondary lymphoid organs are dispensable for the development of T-cell-mediated immunity during tuberculosis.</article-title>
<source>Eur J Immunol</source>
<volume>40</volume>
<fpage>1663</fpage>
<lpage>1673</lpage>
<pub-id pub-id-type="pmid">20222088</pub-id></element-citation></ref><ref id="ppat.1002607-Khader1"><label>37</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khader</surname><given-names>SA</given-names></name><name><surname>Partida-Sanchez</surname><given-names>S</given-names></name><name><surname>Bell</surname><given-names>G</given-names></name><name><surname>Jelley-Gibbs</surname><given-names>DM</given-names></name><name><surname>Swain</surname><given-names>S</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection.</article-title>
<source>J Exp Med</source>
<volume>203</volume>
<fpage>1805</fpage>
<lpage>1815</lpage>
<pub-id pub-id-type="pmid">16818672</pub-id></element-citation></ref><ref id="ppat.1002607-Reece1"><label>38</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reece</surname><given-names>ST</given-names></name><name><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group>
<year>2012</year>
<article-title>Floating between the poles of pathology and protection: can we pin down the granuloma in tuberculosis?</article-title>
<source>Curr Opin Microbiol</source>
<volume>15</volume>
<fpage>63</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="pmid">22074861</pub-id></element-citation></ref><ref id="ppat.1002607-Gutierrez1"><label>39</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gutierrez</surname><given-names>MG</given-names></name><name><surname>Master</surname><given-names>SS</given-names></name><name><surname>Singh</surname><given-names>SB</given-names></name><name><surname>Taylor</surname><given-names>GA</given-names></name><name><surname>Colombo</surname><given-names>MI</given-names></name><etal/></person-group>
<year>2004</year>
<article-title>Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages.</article-title>
<source>Cell</source>
<volume>119</volume>
<fpage>753</fpage>
<lpage>766</lpage>
<pub-id pub-id-type="pmid">15607973</pub-id></element-citation></ref><ref id="ppat.1002607-Deretic1"><label>40</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Deretic</surname><given-names>V</given-names></name></person-group>
<year>2006</year>
<article-title>Autophagy as an immune defense mechanism.</article-title>
<source>Curr Opin Immunol</source>
<volume>18</volume>
<fpage>375</fpage>
<lpage>382</lpage>
<pub-id pub-id-type="pmid">16782319</pub-id></element-citation></ref><ref id="ppat.1002607-Rohde1"><label>41</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rohde</surname><given-names>K</given-names></name><name><surname>Yates</surname><given-names>RM</given-names></name><name><surname>Purdy</surname><given-names>GE</given-names></name><name><surname>Russell</surname><given-names>DG</given-names></name></person-group>
<year>2007</year>
<article-title>Mycobacterium tuberculosis and the environment within the phagosome.</article-title>
<source>Immunol Rev</source>
<volume>219</volume>
<fpage>37</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="pmid">17850480</pub-id></element-citation></ref><ref id="ppat.1002607-Sahiratmadja1"><label>42</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sahiratmadja</surname><given-names>E</given-names></name><name><surname>Alisjahbana</surname><given-names>B</given-names></name><name><surname>de</surname><given-names>BT</given-names></name><name><surname>Adnan</surname><given-names>I</given-names></name><name><surname>Maya</surname><given-names>A</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment.</article-title>
<source>Infect Immun</source>
<volume>75</volume>
<fpage>820</fpage>
<lpage>829</lpage>
<pub-id pub-id-type="pmid">17145950</pub-id></element-citation></ref><ref id="ppat.1002607-vanderWel1"><label>43</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>van der Wel</surname><given-names>N</given-names></name><name><surname>Hava</surname><given-names>D</given-names></name><name><surname>Houben</surname><given-names>D</given-names></name><name><surname>Fluitsma</surname><given-names>D</given-names></name><name><surname>van</surname><given-names>ZM</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells.</article-title>
<source>Cell</source>
<volume>129</volume>
<fpage>1287</fpage>
<lpage>1298</lpage>
<pub-id pub-id-type="pmid">17604718</pub-id></element-citation></ref><ref id="ppat.1002607-Dorhoi1"><label>44</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dorhoi</surname><given-names>A</given-names></name><name><surname>Reece</surname><given-names>ST</given-names></name><name><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group>
<year>2011</year>
<article-title>For better or for worse: the immune response against Mycobacterium tuberculosis balances pathology and protection.</article-title>
<source>Immunol Rev</source>
<volume>240</volume>
<fpage>235</fpage>
<lpage>251</lpage>
<pub-id pub-id-type="pmid">21349097</pub-id></element-citation></ref><ref id="ppat.1002607-Casanova1"><label>45</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Casanova</surname><given-names>JL</given-names></name><name><surname>Abel</surname><given-names>L</given-names></name></person-group>
<year>2002</year>
<article-title>Genetic dissection of immunity to mycobacteria: the human model.</article-title>
<source>Annu Rev Immunol</source>
<volume>20</volume>
<fpage>581</fpage>
<lpage>620</lpage>
<pub-id pub-id-type="pmid">11861613</pub-id></element-citation></ref><ref id="ppat.1002607-Ottenhoff3"><label>46</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ottenhoff</surname><given-names>TH</given-names></name><name><surname>Neuteboom</surname><given-names>S</given-names></name><name><surname>Elferink</surname><given-names>DG</given-names></name><name><surname>de Vries</surname><given-names>RR</given-names></name></person-group>
<year>1986</year>
<article-title>Molecular localization and polymorphism of HLA class II restriction determinants defined by Mycobacterium leprae-reactive helper T cell clones from leprosy patients.</article-title>
<source>J Exp Med</source>
<volume>164</volume>
<fpage>1923</fpage>
<lpage>1939</lpage>
<pub-id pub-id-type="pmid">2431092</pub-id></element-citation></ref><ref id="ppat.1002607-Geluk1"><label>47</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Geluk</surname><given-names>A</given-names></name><name><surname>Bloemhoff</surname><given-names>W</given-names></name><name><surname>de Vries</surname><given-names>RR</given-names></name><name><surname>Ottenhoff</surname><given-names>TH</given-names></name></person-group>
<year>1992</year>
<article-title>Binding of a major T cell epitope of mycobacteria to a specific pocket within HLA-DRw17(DR3) molecules.</article-title>
<source>Eur J Immunol</source>
<volume>22</volume>
<fpage>107</fpage>
<lpage>113</lpage>
<pub-id pub-id-type="pmid">1370411</pub-id></element-citation></ref><ref id="ppat.1002607-Ladel1"><label>48</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ladel</surname><given-names>CH</given-names></name><name><surname>Daugelat</surname><given-names>S</given-names></name><name><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group>
<year>1995</year>
<article-title>Immune response to Mycobacterium bovis bacille Calmette Guerin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance.</article-title>
<source>Eur J Immunol</source>
<volume>25</volume>
<fpage>377</fpage>
<lpage>384</lpage>
<pub-id pub-id-type="pmid">7875199</pub-id></element-citation></ref><ref id="ppat.1002607-Egen1"><label>49</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Egen</surname><given-names>JG</given-names></name><name><surname>Rothfuchs</surname><given-names>AG</given-names></name><name><surname>Feng</surname><given-names>CG</given-names></name><name><surname>Horwitz</surname><given-names>MA</given-names></name><name><surname>Sher</surname><given-names>A</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>Intravital imaging reveals limited antigen presentation and T cell effector function in mycobacterial granulomas.</article-title>
<source>Immunity</source>
<volume>34</volume>
<fpage>807</fpage>
<lpage>819</lpage>
<pub-id pub-id-type="pmid">21596592</pub-id></element-citation></ref><ref id="ppat.1002607-Sallusto1"><label>50</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sallusto</surname><given-names>F</given-names></name><name><surname>Lanzavecchia</surname><given-names>A</given-names></name></person-group>
<year>2009</year>
<article-title>Heterogeneity of CD4&#x0002b; memory T cells: functional modules for tailored immunity.</article-title>
<source>Eur J Immunol</source>
<volume>39</volume>
<fpage>2076</fpage>
<lpage>2082</lpage>
<pub-id pub-id-type="pmid">19672903</pub-id></element-citation></ref><ref id="ppat.1002607-Khader2"><label>51</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khader</surname><given-names>SA</given-names></name><name><surname>Bell</surname><given-names>GK</given-names></name><name><surname>Pearl</surname><given-names>JE</given-names></name><name><surname>Fountain</surname><given-names>JJ</given-names></name><name><surname>Rangel-Moreno</surname><given-names>J</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>IL-23 and IL-17 in the establishment of protective pulmonary CD4&#x0002b; T cell responses after vaccination and during Mycobacterium tuberculosis challenge.</article-title>
<source>Nat Immunol</source>
<volume>8</volume>
<fpage>369</fpage>
<lpage>377</lpage>
<pub-id pub-id-type="pmid">17351619</pub-id></element-citation></ref><ref id="ppat.1002607-Cooper1"><label>52</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cooper</surname><given-names>AM</given-names></name></person-group>
<year>2009</year>
<article-title>Cell-mediated immune responses in tuberculosis.</article-title>
<source>Annu Rev Immunol</source>
<volume>27</volume>
<fpage>393</fpage>
<lpage>422</lpage>
<pub-id pub-id-type="pmid">19302046</pub-id></element-citation></ref><ref id="ppat.1002607-Khader3"><label>53</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khader</surname><given-names>SA</given-names></name><name><surname>Bell</surname><given-names>GK</given-names></name><name><surname>Pearl</surname><given-names>JE</given-names></name><name><surname>Fountain</surname><given-names>JJ</given-names></name><name><surname>Rangel-Moreno</surname><given-names>J</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>IL-23 and IL-17 in the establishment of protective pulmonary CD4&#x0002b; T cell responses after vaccination and during Mycobacterium tuberculosis challenge.</article-title>
<source>Nat Immunol</source>
<volume>8</volume>
<fpage>369</fpage>
<lpage>377</lpage>
<pub-id pub-id-type="pmid">17351619</pub-id></element-citation></ref><ref id="ppat.1002607-Okamoto1"><label>54</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Okamoto</surname><given-names>YY</given-names></name><name><surname>Umemura</surname><given-names>M</given-names></name><name><surname>Yahagi</surname><given-names>A</given-names></name><name><surname>O'Brien</surname><given-names>RL</given-names></name><name><surname>Ikuta</surname><given-names>K</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung.</article-title>
<source>J Immunol</source>
<volume>184</volume>
<fpage>4414</fpage>
<lpage>4422</lpage>
<pub-id pub-id-type="pmid">20212094</pub-id></element-citation></ref><ref id="ppat.1002607-Cruz1"><label>55</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cruz</surname><given-names>A</given-names></name><name><surname>Fraga</surname><given-names>AG</given-names></name><name><surname>Fountain</surname><given-names>JJ</given-names></name><name><surname>Rangel-Moreno</surname><given-names>J</given-names></name><name><surname>Torrado</surname><given-names>E</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis.</article-title>
<source>J Exp Med</source>
<volume>207</volume>
<fpage>1609</fpage>
<lpage>1616</lpage>
<pub-id pub-id-type="pmid">20624887</pub-id></element-citation></ref><ref id="ppat.1002607-Torrado1"><label>56</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Torrado</surname><given-names>E</given-names></name><name><surname>Robinson</surname><given-names>RT</given-names></name><name><surname>Cooper</surname><given-names>AM</given-names></name></person-group>
<year>2011</year>
<article-title>Cellular response to mycobacteria: balancing protection and pathology.</article-title>
<source>Trends Immunol</source>
<volume>32</volume>
<fpage>66</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="pmid">21216195</pub-id></element-citation></ref><ref id="ppat.1002607-Ottenhoff4"><label>57</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Ottenhoff</surname><given-names>TH</given-names></name><name><surname>Lewinsohn</surname><given-names>DA</given-names></name><name><surname>Lewinsohn</surname><given-names>DM</given-names></name></person-group>
<year>2008</year>
<article-title>Human CD4 and CD8 T cell responses to Mycobacterium tuberculosis: antigen specificity, function, implications and applications.</article-title>
<source>Handbook of tuberculosis. Immunology and cell biology</source>
<publisher-loc>Weinheim, Germany</publisher-loc>
<publisher-name>Wiley-VCH Verlag GmbH &#x00026; Co.KGaA</publisher-name>
<fpage>119</fpage>
<lpage>156</lpage>
</element-citation></ref><ref id="ppat.1002607-Schaible1"><label>58</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schaible</surname><given-names>UE</given-names></name><name><surname>Winau</surname><given-names>F</given-names></name><name><surname>Sieling</surname><given-names>PA</given-names></name><name><surname>Fischer</surname><given-names>K</given-names></name><name><surname>Collins</surname><given-names>HL</given-names></name><etal/></person-group>
<year>2003</year>
<article-title>Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis.</article-title>
<source>Nat Med</source>
<volume>9</volume>
<fpage>1039</fpage>
<lpage>1046</lpage>
<pub-id pub-id-type="pmid">12872166</pub-id></element-citation></ref><ref id="ppat.1002607-Winau1"><label>59</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Winau</surname><given-names>F</given-names></name><name><surname>Weber</surname><given-names>S</given-names></name><name><surname>Sad</surname><given-names>S</given-names></name><name><surname>de</surname><given-names>DJ</given-names></name><name><surname>Hoops</surname><given-names>SL</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis.</article-title>
<source>Immunity</source>
<volume>24</volume>
<fpage>105</fpage>
<lpage>117</lpage>
<pub-id pub-id-type="pmid">16413927</pub-id></element-citation></ref><ref id="ppat.1002607-Levine1"><label>60</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Levine</surname><given-names>B</given-names></name><name><surname>Mizushima</surname><given-names>N</given-names></name><name><surname>Virgin</surname><given-names>HW</given-names></name></person-group>
<year>2011</year>
<article-title>Autophagy in immunity and inflammation.</article-title>
<source>Nature</source>
<volume>469</volume>
<fpage>323</fpage>
<lpage>335</lpage>
<pub-id pub-id-type="pmid">21248839</pub-id></element-citation></ref><ref id="ppat.1002607-Deretic2"><label>61</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Deretic</surname><given-names>V</given-names></name></person-group>
<year>2010</year>
<article-title>Autophagy in infection.</article-title>
<source>Curr Opin Cell Biol</source>
<volume>22</volume>
<fpage>252</fpage>
<lpage>262</lpage>
<pub-id pub-id-type="pmid">20116986</pub-id></element-citation></ref><ref id="ppat.1002607-Rolph1"><label>62</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rolph</surname><given-names>MS</given-names></name><name><surname>Raupach</surname><given-names>B</given-names></name><name><surname>Kobernick</surname><given-names>HH</given-names></name><name><surname>Collins</surname><given-names>HL</given-names></name><name><surname>Perarnau</surname><given-names>B</given-names></name><etal/></person-group>
<year>2001</year>
<article-title>MHC class Ia-restricted T cells partially account for beta2-microglobulin-dependent resistance to Mycobacterium tuberculosis.</article-title>
<source>Eur J Immunol</source>
<volume>31</volume>
<fpage>1944</fpage>
<lpage>1949</lpage>
<pub-id pub-id-type="pmid">11433392</pub-id></element-citation></ref><ref id="ppat.1002607-Schaible2"><label>63</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schaible</surname><given-names>UE</given-names></name><name><surname>Collins</surname><given-names>HL</given-names></name><name><surname>Priem</surname><given-names>F</given-names></name><name><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group>
<year>2002</year>
<article-title>Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis.</article-title>
<source>J Exp Med</source>
<volume>196</volume>
<fpage>1507</fpage>
<lpage>1513</lpage>
<pub-id pub-id-type="pmid">12461085</pub-id></element-citation></ref><ref id="ppat.1002607-Joosten1"><label>64</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Joosten</surname><given-names>SA</given-names></name><name><surname>van Meijgaarden</surname><given-names>KE</given-names></name><name><surname>van Weeren</surname><given-names>PC</given-names></name><name><surname>Kazi</surname><given-names>F</given-names></name><name><surname>Geluk</surname><given-names>A</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity.</article-title>
<source>PLoS Pathog</source>
<volume>6</volume>
<fpage>e1000782</fpage>
<comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.1000782">10.1371/journal.ppat.1000782</ext-link></comment>
<pub-id pub-id-type="pmid">20195504</pub-id></element-citation></ref><ref id="ppat.1002607-Heinzel1"><label>65</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Heinzel</surname><given-names>AS</given-names></name><name><surname>Grotzke</surname><given-names>JE</given-names></name><name><surname>Lines</surname><given-names>RA</given-names></name><name><surname>Lewinsohn</surname><given-names>DA</given-names></name><name><surname>McNabb</surname><given-names>AL</given-names></name><etal/></person-group>
<year>2002</year>
<article-title>HLA-E-dependent presentation of Mtb-derived antigen to human CD8&#x0002b; T cells.</article-title>
<source>J Exp Med</source>
<volume>196</volume>
<fpage>1473</fpage>
<lpage>1481</lpage>
<pub-id pub-id-type="pmid">12461082</pub-id></element-citation></ref><ref id="ppat.1002607-Gold1"><label>66</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gold</surname><given-names>MC</given-names></name><name><surname>Cerri</surname><given-names>S</given-names></name><name><surname>Smyk-Pearson</surname><given-names>S</given-names></name><name><surname>Cansler</surname><given-names>ME</given-names></name><name><surname>Vogt</surname><given-names>TM</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>Human mucosal associated invariant T cells detect bacterially infected cells.</article-title>
<source>PLoS Biol</source>
<volume>8</volume>
<fpage>e1000407</fpage>
<comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pbio.1000407">10.1371/journal.pbio.1000407</ext-link></comment>
<pub-id pub-id-type="pmid">20613858</pub-id></element-citation></ref><ref id="ppat.1002607-HernandezPando1"><label>67</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hernandez-Pando</surname><given-names>R</given-names></name><name><surname>Jeyanathan</surname><given-names>M</given-names></name><name><surname>Mengistu</surname><given-names>G</given-names></name><name><surname>Aguilar</surname><given-names>D</given-names></name><name><surname>Orozco</surname><given-names>H</given-names></name><etal/></person-group>
<year>2000</year>
<article-title>Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection.</article-title>
<source>Lancet</source>
<volume>356</volume>
<fpage>2133</fpage>
<lpage>2138</lpage>
<pub-id pub-id-type="pmid">11191539</pub-id></element-citation></ref><ref id="ppat.1002607-Keane2"><label>68</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Keane</surname><given-names>J</given-names></name><name><surname>Remold</surname><given-names>HG</given-names></name><name><surname>Kornfeld</surname><given-names>H</given-names></name></person-group>
<year>2000</year>
<article-title>Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages.</article-title>
<source>J Immunol</source>
<volume>164</volume>
<fpage>2016</fpage>
<lpage>2020</lpage>
<pub-id pub-id-type="pmid">10657653</pub-id></element-citation></ref><ref id="ppat.1002607-Stenger1"><label>69</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stenger</surname><given-names>S</given-names></name><name><surname>Hanson</surname><given-names>DA</given-names></name><name><surname>Teitelbaum</surname><given-names>R</given-names></name><name><surname>Dewan</surname><given-names>P</given-names></name><name><surname>Niazi</surname><given-names>KR</given-names></name><etal/></person-group>
<year>1998</year>
<article-title>An antimicrobial activity of cytolytic T cells mediated by granulysin.</article-title>
<source>Science</source>
<volume>282</volume>
<fpage>121</fpage>
<lpage>125</lpage>
<pub-id pub-id-type="pmid">9756476</pub-id></element-citation></ref><ref id="ppat.1002607-Caccamo1"><label>70</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Caccamo</surname><given-names>N</given-names></name><name><surname>Meraviglia</surname><given-names>S</given-names></name><name><surname>La</surname><given-names>MC</given-names></name><name><surname>Guggino</surname><given-names>G</given-names></name><name><surname>Dieli</surname><given-names>F</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>Phenotypical and functional analysis of memory and effector human CD8 T cells specific for mycobacterial antigens.</article-title>
<source>J Immunol</source>
<volume>177</volume>
<fpage>1780</fpage>
<lpage>1785</lpage>
<pub-id pub-id-type="pmid">16849488</pub-id></element-citation></ref><ref id="ppat.1002607-Tang1"><label>71</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tang</surname><given-names>H</given-names></name><name><surname>Pang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Xiao</surname><given-names>X</given-names></name><name><surname>Rong</surname><given-names>Y</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>TLR4 activation is required for IL-17-induced multiple tissue inflammation and wasting in mice.</article-title>
<source>J Immunol</source>
<volume>185</volume>
<fpage>2563</fpage>
<lpage>2569</lpage>
<pub-id pub-id-type="pmid">20631308</pub-id></element-citation></ref><ref id="ppat.1002607-Kagina1"><label>72</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kagina</surname><given-names>BM</given-names></name><name><surname>Abel</surname><given-names>B</given-names></name><name><surname>Scriba</surname><given-names>TJ</given-names></name><name><surname>Hughes</surname><given-names>EJ</given-names></name><name><surname>Keyser</surname><given-names>A</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guerin vaccination of newborns.</article-title>
<source>Am J Respir Crit Care Med</source>
<volume>182</volume>
<fpage>1073</fpage>
<lpage>1079</lpage>
<pub-id pub-id-type="pmid">20558627</pub-id></element-citation></ref><ref id="ppat.1002607-Gaseitsiwe1"><label>73</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gaseitsiwe</surname><given-names>S</given-names></name><name><surname>Valentini</surname><given-names>D</given-names></name><name><surname>Mahdavifar</surname><given-names>S</given-names></name><name><surname>Reilly</surname><given-names>M</given-names></name><name><surname>Ehrnst</surname><given-names>A</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>Peptide microarray-based identification of Mycobacterium tuberculosis epitope binding to HLA-DRB1&#x0002a;0101, DRB1&#x0002a;1501, and DRB1&#x0002a;0401.</article-title>
<source>Clin Vaccine Immunol</source>
<volume>17</volume>
<fpage>168</fpage>
<lpage>175</lpage>
<pub-id pub-id-type="pmid">19864486</pub-id></element-citation></ref><ref id="ppat.1002607-Lewinsohn1"><label>74</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lewinsohn</surname><given-names>DA</given-names></name><name><surname>Winata</surname><given-names>E</given-names></name><name><surname>Swarbrick</surname><given-names>GM</given-names></name><name><surname>Tanner</surname><given-names>KE</given-names></name><name><surname>Cook</surname><given-names>MS</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B.</article-title>
<source>PLoS Pathog</source>
<volume>3</volume>
<fpage>e127</fpage>
<comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.0030127">10.1371/journal.ppat.0030127</ext-link></comment>
</element-citation></ref><ref id="ppat.1002607-Commandeur1"><label>75</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Commandeur</surname><given-names>S</given-names></name><name><surname>van Meijgaarden</surname><given-names>KE</given-names></name><name><surname>Lin</surname><given-names>MY</given-names></name><name><surname>Franken</surname><given-names>KL</given-names></name><name><surname>Friggen</surname><given-names>AH</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>Identification of human T-cell responses to Mycobacterium tuberculosis resuscitation-promoting factors in long-term latently infected individuals.</article-title>
<source>Clin Vaccine Immunol</source>
<volume>18</volume>
<fpage>676</fpage>
<lpage>683</lpage>
<pub-id pub-id-type="pmid">21248154</pub-id></element-citation></ref><ref id="ppat.1002607-Maglione1"><label>76</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maglione</surname><given-names>PJ</given-names></name><name><surname>Chan</surname><given-names>J</given-names></name></person-group>
<year>2009</year>
<article-title>How B cells shape the immune response against Mycobacterium tuberculosis.</article-title>
<source>Eur J Immunol</source>
<volume>39</volume>
<fpage>676</fpage>
<lpage>686</lpage>
<pub-id pub-id-type="pmid">19283721</pub-id></element-citation></ref><ref id="ppat.1002607-Berry1"><label>77</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Berry</surname><given-names>MP</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Bloch</surname><given-names>SA</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.</article-title>
<source>Nature</source>
<volume>466</volume>
<fpage>973</fpage>
<lpage>977</lpage>
<pub-id pub-id-type="pmid">20725040</pub-id></element-citation></ref><ref id="ppat.1002607-Maertzdorf1"><label>78</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maertzdorf</surname><given-names>J</given-names></name><name><surname>Repsilber</surname><given-names>D</given-names></name><name><surname>Parida</surname><given-names>SK</given-names></name><name><surname>Stanley</surname><given-names>K</given-names></name><name><surname>Roberts</surname><given-names>T</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>Human gene expression profiles of susceptibility and resistance in tuberculosis.</article-title>
<source>Genes Immun</source>
<volume>12</volume>
<fpage>15</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="pmid">20861863</pub-id></element-citation></ref><ref id="ppat.1002607-Caccamo2"><label>79</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Caccamo</surname><given-names>N</given-names></name><name><surname>Guggino</surname><given-names>G</given-names></name><name><surname>Meraviglia</surname><given-names>S</given-names></name><name><surname>Gelsomino</surname><given-names>G</given-names></name><name><surname>Di</surname><given-names>CP</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Analysis of Mycobacterium tuberculosis-specific CD8 T-cells in patients with active tuberculosis and in individuals with latent infection.</article-title>
<source>PLoS ONE</source>
<volume>4</volume>
<fpage>e5528</fpage>
<comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0005528">10.1371/journal.pone.0005528</ext-link></comment>
<pub-id pub-id-type="pmid">19436760</pub-id></element-citation></ref><ref id="ppat.1002607-Darrah1"><label>80</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Darrah</surname><given-names>PA</given-names></name><name><surname>Patel</surname><given-names>DT</given-names></name><name><surname>De Luca</surname><given-names>PM</given-names></name><name><surname>Lindsay</surname><given-names>RW</given-names></name><name><surname>Davey</surname><given-names>DF</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major.</article-title>
<source>Nat Med</source>
<volume>13</volume>
<fpage>843</fpage>
<lpage>850</lpage>
<pub-id pub-id-type="pmid">17558415</pub-id></element-citation></ref><ref id="ppat.1002607-Derrick1"><label>81</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Derrick</surname><given-names>SC</given-names></name><name><surname>Yabe</surname><given-names>IM</given-names></name><name><surname>Yang</surname><given-names>A</given-names></name><name><surname>Morris</surname><given-names>SL</given-names></name></person-group>
<year>2011</year>
<article-title>Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells.</article-title>
<source>Vaccine</source>
<volume>29</volume>
<fpage>2902</fpage>
<lpage>2909</lpage>
<pub-id pub-id-type="pmid">21338678</pub-id></element-citation></ref><ref id="ppat.1002607-Sutherland1"><label>82</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sutherland</surname><given-names>JS</given-names></name><name><surname>Adetifa</surname><given-names>IM</given-names></name><name><surname>Hill</surname><given-names>PC</given-names></name><name><surname>Adegbola</surname><given-names>RA</given-names></name><name><surname>Ota</surname><given-names>MO</given-names></name></person-group>
<year>2009</year>
<article-title>Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease.</article-title>
<source>Eur J Immunol</source>
<volume>39</volume>
<fpage>723</fpage>
<lpage>729</lpage>
<pub-id pub-id-type="pmid">19224636</pub-id></element-citation></ref><ref id="ppat.1002607-Caccamo3"><label>83</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Caccamo</surname><given-names>N</given-names></name><name><surname>Guggino</surname><given-names>G</given-names></name><name><surname>Joosten</surname><given-names>SA</given-names></name><name><surname>Gelsomino</surname><given-names>G</given-names></name><name><surname>Di</surname><given-names>CP</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>Multifunctional CD4(&#x0002b;) T cells correlate with active Mycobacterium tuberculosis infection.</article-title>
<source>Eur J Immunol</source>
<volume>40</volume>
<fpage>2211</fpage>
<lpage>2220</lpage>
<pub-id pub-id-type="pmid">20540114</pub-id></element-citation></ref><ref id="ppat.1002607-Smith1"><label>84</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Smith</surname><given-names>SG</given-names></name><name><surname>Lalor</surname><given-names>MK</given-names></name><name><surname>Gorak-Stolinska</surname><given-names>P</given-names></name><name><surname>Blitz</surname><given-names>R</given-names></name><name><surname>Beveridge</surname><given-names>NE</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining.</article-title>
<source>BMC Immunol</source>
<volume>11</volume>
<fpage>35</fpage>
<pub-id pub-id-type="pmid">20609237</pub-id></element-citation></ref><ref id="ppat.1002607-Young1"><label>85</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Young</surname><given-names>DB</given-names></name><name><surname>Gideon</surname><given-names>HP</given-names></name><name><surname>Wilkinson</surname><given-names>RJ</given-names></name></person-group>
<year>2009</year>
<article-title>Eliminating latent tuberculosis.</article-title>
<source>Trends Microbiol</source>
<volume>17</volume>
<fpage>183</fpage>
<lpage>138</lpage>
<pub-id pub-id-type="pmid">19375916</pub-id></element-citation></ref><ref id="ppat.1002607-Shafiani1"><label>86</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shafiani</surname><given-names>S</given-names></name><name><surname>Tucker-Heard</surname><given-names>G</given-names></name><name><surname>Kariyone</surname><given-names>A</given-names></name><name><surname>Takatsu</surname><given-names>K</given-names></name><name><surname>Urdahl</surname><given-names>KB</given-names></name></person-group>
<year>2010</year>
<article-title>Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis.</article-title>
<source>J Exp Med</source>
<volume>207</volume>
<fpage>1409</fpage>
<lpage>1420</lpage>
<pub-id pub-id-type="pmid">20547826</pub-id></element-citation></ref><ref id="ppat.1002607-Kursar1"><label>87</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kursar</surname><given-names>M</given-names></name><name><surname>Koch</surname><given-names>M</given-names></name><name><surname>Mittrucker</surname><given-names>HW</given-names></name><name><surname>Nouailles</surname><given-names>G</given-names></name><name><surname>Bonhagen</surname><given-names>K</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>Cutting Edge: Regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis.</article-title>
<source>J Immunol</source>
<volume>178</volume>
<fpage>2661</fpage>
<lpage>2665</lpage>
<pub-id pub-id-type="pmid">17312107</pub-id></element-citation></ref><ref id="ppat.1002607-Joosten2"><label>88</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Joosten</surname><given-names>SA</given-names></name><name><surname>van Meijgaarden</surname><given-names>KE</given-names></name><name><surname>Savage</surname><given-names>ND</given-names></name><name><surname>de</surname><given-names>BT</given-names></name><name><surname>Triebel</surname><given-names>F</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>Identification of a human CD8&#x0002b; regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4.</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>104</volume>
<fpage>8029</fpage>
<lpage>8034</lpage>
<pub-id pub-id-type="pmid">17483450</pub-id></element-citation></ref><ref id="ppat.1002607-Joosten3"><label>89</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Joosten</surname><given-names>SA</given-names></name><name><surname>Ottenhoff</surname><given-names>TH</given-names></name></person-group>
<year>2008</year>
<article-title>Human CD4 and CD8 regulatory T cells in infectious diseases and vaccination.</article-title>
<source>Hum Immunol</source>
<volume>69</volume>
<fpage>760</fpage>
<lpage>770</lpage>
<pub-id pub-id-type="pmid">18835413</pub-id></element-citation></ref><ref id="ppat.1002607-Ottenhoff5"><label>90</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ottenhoff</surname><given-names>TH</given-names></name><name><surname>Doherty</surname><given-names>TM</given-names></name><name><surname>van Dissel</surname><given-names>JT</given-names></name><name><surname>Bang</surname><given-names>P</given-names></name><name><surname>Lingnau</surname><given-names>K</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>First in humans: a new molecularly defined vaccine shows excellent safety and strong induction of long-lived Mycobacterium tuberculosis-specific Th1-cell like responses.</article-title>
<source>Hum Vaccin</source>
<volume>6</volume>
<fpage>1007</fpage>
<lpage>1015</lpage>
<pub-id pub-id-type="pmid">21178394</pub-id></element-citation></ref><ref id="ppat.1002607-Brodin1"><label>91</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brodin</surname><given-names>P</given-names></name><name><surname>Majlessi</surname><given-names>L</given-names></name><name><surname>Brosch</surname><given-names>R</given-names></name><name><surname>Smith</surname><given-names>D</given-names></name><name><surname>Bancroft</surname><given-names>G</given-names></name><etal/></person-group>
<year>2004</year>
<article-title>Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.</article-title>
<source>J Infect Dis</source>
<volume>190</volume>
<fpage>115</fpage>
<lpage>122</lpage>
<pub-id pub-id-type="pmid">15195250</pub-id></element-citation></ref><ref id="ppat.1002607-Sweeney1"><label>92</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sweeney</surname><given-names>KA</given-names></name><name><surname>Dao</surname><given-names>DN</given-names></name><name><surname>Goldberg</surname><given-names>MF</given-names></name><name><surname>Hsu</surname><given-names>T</given-names></name><name><surname>Venkataswamy</surname><given-names>MM</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis.</article-title>
<source>Nat Med</source>
<volume>17</volume>
<fpage>1261</fpage>
<lpage>1268</lpage>
<pub-id pub-id-type="pmid">21892180</pub-id></element-citation></ref><ref id="ppat.1002607-Tullius1"><label>93</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tullius</surname><given-names>MV</given-names></name><name><surname>Harth</surname><given-names>G</given-names></name><name><surname>Maslesa-Galic</surname><given-names>S</given-names></name><name><surname>Dillon</surname><given-names>BJ</given-names></name><name><surname>Horwitz</surname><given-names>MA</given-names></name></person-group>
<year>2008</year>
<article-title>A Replication-Limited Recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for human immunodeficiency virus-positive persons is safer and more efficacious than BCG.</article-title>
<source>Infect Immun</source>
<volume>76</volume>
<fpage>5200</fpage>
<lpage>5214</lpage>
<pub-id pub-id-type="pmid">18725418</pub-id></element-citation></ref><ref id="ppat.1002607-Hoft1"><label>94</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hoft</surname><given-names>DF</given-names></name><name><surname>Blazevic</surname><given-names>A</given-names></name><name><surname>Abate</surname><given-names>G</given-names></name><name><surname>Hanekom</surname><given-names>WA</given-names></name><name><surname>Kaplan</surname><given-names>G</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>A new recombinant bacille Calmette-Guerin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers.</article-title>
<source>J Infect Dis</source>
<volume>198</volume>
<fpage>1491</fpage>
<lpage>1501</lpage>
<pub-id pub-id-type="pmid">18808333</pub-id></element-citation></ref><ref id="ppat.1002607-Pym1"><label>95</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pym</surname><given-names>AS</given-names></name><name><surname>Brodin</surname><given-names>P</given-names></name><name><surname>Majlessi</surname><given-names>L</given-names></name><name><surname>Brosch</surname><given-names>R</given-names></name><name><surname>Demangel</surname><given-names>C</given-names></name><etal/></person-group>
<year>2003</year>
<article-title>Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis.</article-title>
<source>Nat Med</source>
<volume>9</volume>
<fpage>533</fpage>
<lpage>539</lpage>
<pub-id pub-id-type="pmid">12692540</pub-id></element-citation></ref><ref id="ppat.1002607-Sun1"><label>96</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sun</surname><given-names>R</given-names></name><name><surname>Skeiky</surname><given-names>YA</given-names></name><name><surname>Izzo</surname><given-names>A</given-names></name><name><surname>Dheenadhayalan</surname><given-names>V</given-names></name><name><surname>Imam</surname><given-names>Z</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.</article-title>
<source>Vaccine</source>
<volume>27</volume>
<fpage>4412</fpage>
<lpage>4423</lpage>
<pub-id pub-id-type="pmid">19500523</pub-id></element-citation></ref><ref id="ppat.1002607-Grode1"><label>97</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grode</surname><given-names>L</given-names></name><name><surname>Seiler</surname><given-names>P</given-names></name><name><surname>Baumann</surname><given-names>S</given-names></name><name><surname>Hess</surname><given-names>J</given-names></name><name><surname>Brinkmann</surname><given-names>V</given-names></name><etal/></person-group>
<year>2005</year>
<article-title>Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin.</article-title>
<source>J Clin Invest</source>
<volume>115</volume>
<fpage>2472</fpage>
<lpage>2479</lpage>
<pub-id pub-id-type="pmid">16110326</pub-id></element-citation></ref><ref id="ppat.1002607-Decatur1"><label>98</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Decatur</surname><given-names>AL</given-names></name><name><surname>Portnoy</surname><given-names>DA</given-names></name></person-group>
<year>2000</year>
<article-title>A PEST-like sequence in listeriolysin O essential for Listeria monocytogenes pathogenicity.</article-title>
<source>Science</source>
<volume>290</volume>
<fpage>992</fpage>
<lpage>995</lpage>
<pub-id pub-id-type="pmid">11062133</pub-id></element-citation></ref><ref id="ppat.1002607-Palmer1"><label>99</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Palmer</surname><given-names>M</given-names></name></person-group>
<year>2001</year>
<article-title>The family of thiol-activated, cholesterol-binding cytolysins.</article-title>
<source>Toxicon</source>
<volume>39</volume>
<fpage>1681</fpage>
<lpage>1689</lpage>
<pub-id pub-id-type="pmid">11595631</pub-id></element-citation></ref><ref id="ppat.1002607-Torchinsky1"><label>100</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Torchinsky</surname><given-names>MB</given-names></name><name><surname>Garaude</surname><given-names>J</given-names></name><name><surname>Martin</surname><given-names>AP</given-names></name><name><surname>Blander</surname><given-names>JM</given-names></name></person-group>
<year>2009</year>
<article-title>Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation.</article-title>
<source>Nature</source>
<volume>458</volume>
<fpage>78</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="pmid">19262671</pub-id></element-citation></ref><ref id="ppat.1002607-Desel1"><label>101</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Desel</surname><given-names>C</given-names></name><name><surname>Dorhoi</surname><given-names>A</given-names></name><name><surname>Bandermann</surname><given-names>S</given-names></name><name><surname>Grode</surname><given-names>L</given-names></name><name><surname>Eisele</surname><given-names>B</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>Recombinant BCG {Delta}ureC hly&#x0002b; Induces Superior Protection Over Parental BCG by Stimulating a Balanced Combination of Type 1 and Type 17 Cytokine Responses.</article-title>
<source>J Infect Dis</source>
<volume>204</volume>
<fpage>1573</fpage>
<lpage>1584</lpage>
<pub-id pub-id-type="pmid">21933877</pub-id></element-citation></ref><ref id="ppat.1002607-Mollenkopf1"><label>102</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mollenkopf</surname><given-names>HJ</given-names></name><name><surname>Grode</surname><given-names>L</given-names></name><name><surname>Mattow</surname><given-names>J</given-names></name><name><surname>Stein</surname><given-names>M</given-names></name><name><surname>Mann</surname><given-names>P</given-names></name><etal/></person-group>
<year>2004</year>
<article-title>Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis.</article-title>
<source>Infect Immun</source>
<volume>72</volume>
<fpage>6471</fpage>
<lpage>6479</lpage>
<pub-id pub-id-type="pmid">15501778</pub-id></element-citation></ref><ref id="ppat.1002607-Kupferschmidt1"><label>103</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kupferschmidt</surname><given-names>K</given-names></name></person-group>
<year>2011</year>
<article-title>Infectious disease. Taking a new shot at a TB vaccine.</article-title>
<source>Science</source>
<volume>334</volume>
<fpage>1488</fpage>
<lpage>1490</lpage>
<pub-id pub-id-type="pmid">22174226</pub-id></element-citation></ref><ref id="ppat.1002607-Guleria1"><label>104</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guleria</surname><given-names>I</given-names></name><name><surname>Teitelbaum</surname><given-names>R</given-names></name><name><surname>McAdam</surname><given-names>RA</given-names></name><name><surname>Kalpana</surname><given-names>G</given-names></name><name><surname>Jacobs</surname><given-names>WR</given-names><suffix>Jr</suffix></name><etal/></person-group>
<year>1996</year>
<article-title>Auxotrophic vaccines for tuberculosis.</article-title>
<source>Nat Med</source>
<volume>2</volume>
<fpage>334</fpage>
<lpage>337</lpage>
<pub-id pub-id-type="pmid">8612234</pub-id></element-citation></ref><ref id="ppat.1002607-Sambandamurthy1"><label>105</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sambandamurthy</surname><given-names>VK</given-names></name><name><surname>Derrick</surname><given-names>SC</given-names></name><name><surname>Hsu</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Larsen</surname><given-names>MH</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis.</article-title>
<source>Vaccine</source>
<volume>24</volume>
<fpage>6309</fpage>
<lpage>6320</lpage>
<pub-id pub-id-type="pmid">16860907</pub-id></element-citation></ref><ref id="ppat.1002607-Martin1"><label>106</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Martin</surname><given-names>C</given-names></name><name><surname>Williams</surname><given-names>A</given-names></name><name><surname>Hernandez-Pando</surname><given-names>R</given-names></name><name><surname>Cardona</surname><given-names>PJ</given-names></name><name><surname>Gormley</surname><given-names>E</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs.</article-title>
<source>Vaccine</source>
<volume>24</volume>
<fpage>3408</fpage>
<lpage>3419</lpage>
<pub-id pub-id-type="pmid">16564606</pub-id></element-citation></ref><ref id="ppat.1002607-Lee1"><label>107</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Krause</surname><given-names>R</given-names></name><name><surname>Schreiber</surname><given-names>J</given-names></name><name><surname>Mollenkopf</surname><given-names>HJ</given-names></name><name><surname>Kowall</surname><given-names>J</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>Mutation in the transcriptional regulator PhoP contributes to avirulence of Mycobacterium tuberculosis H37Ra strain.</article-title>
<source>Cell Host Microbe</source>
<volume>3</volume>
<fpage>97</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="pmid">18312844</pub-id></element-citation></ref><ref id="ppat.1002607-McShane1"><label>108</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McShane</surname><given-names>H</given-names></name><name><surname>Pathan</surname><given-names>AA</given-names></name><name><surname>Sander</surname><given-names>CR</given-names></name><name><surname>Keating</surname><given-names>SM</given-names></name><name><surname>Gilbert</surname><given-names>SC</given-names></name><etal/></person-group>
<year>2004</year>
<article-title>Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.</article-title>
<source>Nat Med</source>
<volume>10</volume>
<fpage>1240</fpage>
<lpage>1244</lpage>
<pub-id pub-id-type="pmid">15502839</pub-id></element-citation></ref><ref id="ppat.1002607-Scriba1"><label>109</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Scriba</surname><given-names>TJ</given-names></name><name><surname>Tameris</surname><given-names>M</given-names></name><name><surname>Mansoor</surname><given-names>N</given-names></name><name><surname>Smit</surname><given-names>E</given-names></name><name><surname>van der Merwe</surname><given-names>L</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4&#x0002b; T cells.</article-title>
<source>Eur J Immunol</source>
<volume>40</volume>
<fpage>279</fpage>
<lpage>290</lpage>
<pub-id pub-id-type="pmid">20017188</pub-id></element-citation></ref><ref id="ppat.1002607-Radosevic1"><label>110</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Radosevic</surname><given-names>K</given-names></name><name><surname>Wieland</surname><given-names>CW</given-names></name><name><surname>Rodriguez</surname><given-names>A</given-names></name><name><surname>Weverling</surname><given-names>GJ</given-names></name><name><surname>Mintardjo</surname><given-names>R</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon.</article-title>
<source>Infect Immun</source>
<volume>75</volume>
<fpage>4105</fpage>
<lpage>4115</lpage>
<pub-id pub-id-type="pmid">17526747</pub-id></element-citation></ref><ref id="ppat.1002607-Abel1"><label>111</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abel</surname><given-names>B</given-names></name><name><surname>Tameris</surname><given-names>M</given-names></name><name><surname>Mansoor</surname><given-names>N</given-names></name><name><surname>Gelderbloem</surname><given-names>S</given-names></name><name><surname>Hughes</surname><given-names>J</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4&#x0002b; and CD8&#x0002b; T cells in adults.</article-title>
<source>Am J Respir Crit Care Med</source>
<volume>181</volume>
<fpage>1407</fpage>
<lpage>1417</lpage>
<pub-id pub-id-type="pmid">20167847</pub-id></element-citation></ref><ref id="ppat.1002607-Hutnick1"><label>112</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hutnick</surname><given-names>NA</given-names></name><name><surname>Carnathan</surname><given-names>DG</given-names></name><name><surname>Dubey</surname><given-names>SA</given-names></name><name><surname>Makedonas</surname><given-names>G</given-names></name><name><surname>Cox</surname><given-names>KS</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Baseline Ad5 serostatus does not predict Ad5 HIV vaccine-induced expansion of adenovirus-specific CD4&#x0002b; T cells.</article-title>
<source>Nat Med</source>
<volume>15</volume>
<fpage>876</fpage>
<lpage>878</lpage>
<pub-id pub-id-type="pmid">19620962</pub-id></element-citation></ref><ref id="ppat.1002607-Flatz1"><label>113</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Flatz</surname><given-names>L</given-names></name><name><surname>Hegazy</surname><given-names>AN</given-names></name><name><surname>Bergthaler</surname><given-names>A</given-names></name><name><surname>Verschoor</surname><given-names>A</given-names></name><name><surname>Claus</surname><given-names>C</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8&#x0002b; T cell immunity.</article-title>
<source>Nat Med</source>
<volume>16</volume>
<fpage>339</fpage>
<lpage>345</lpage>
<pub-id pub-id-type="pmid">20139992</pub-id></element-citation></ref><ref id="ppat.1002607-vanDissel1"><label>114</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>van Dissel</surname><given-names>JT</given-names></name><name><surname>Arend</surname><given-names>SM</given-names></name><name><surname>Prins</surname><given-names>C</given-names></name><name><surname>Bang</surname><given-names>P</given-names></name><name><surname>Tingskov</surname><given-names>PN</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naive human volunteers.</article-title>
<source>Vaccine</source>
<volume>28</volume>
<fpage>3571</fpage>
<lpage>3581</lpage>
<pub-id pub-id-type="pmid">20226890</pub-id></element-citation></ref><ref id="ppat.1002607-vanDissel2"><label>115</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>van Dissel</surname><given-names>JT</given-names></name><name><surname>Soonawala</surname><given-names>D</given-names></name><name><surname>Joosten</surname><given-names>SA</given-names></name><name><surname>Prins</surname><given-names>C</given-names></name><name><surname>Arend</surname><given-names>SM</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>Ag85B-ESAT-6 adjuvanted with IC31(R) promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection.</article-title>
<source>Vaccine</source>
<volume>29</volume>
<fpage>2100</fpage>
<lpage>2109</lpage>
<pub-id pub-id-type="pmid">21256189</pub-id></element-citation></ref><ref id="ppat.1002607-VonEschen1"><label>116</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Von Eschen</surname><given-names>K</given-names></name><name><surname>Morrison</surname><given-names>R</given-names></name><name><surname>Braun</surname><given-names>M</given-names></name><name><surname>Ofori-Anyinam</surname><given-names>O</given-names></name><name><surname>De</surname><given-names>KE</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>The candidate tuberculosis vaccine Mtb72F/AS02A: Tolerability and immunogenicity in humans.</article-title>
<source>Hum Vaccin</source>
<volume>5</volume>
<fpage>475</fpage>
<lpage>482</lpage>
<pub-id pub-id-type="pmid">19587528</pub-id></element-citation></ref><ref id="ppat.1002607-Davidsen1"><label>117</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Davidsen</surname><given-names>J</given-names></name><name><surname>Rosenkrands</surname><given-names>I</given-names></name><name><surname>Christensen</surname><given-names>D</given-names></name><name><surname>Vangala</surname><given-names>A</given-names></name><name><surname>Kirby</surname><given-names>D</given-names></name><etal/></person-group>
<year>2005</year>
<article-title>Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6&#x02032;-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses.</article-title>
<source>Biochim Biophys Acta</source>
<volume>1718</volume>
<fpage>22</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="pmid">16321607</pub-id></element-citation></ref><ref id="ppat.1002607-Agger1"><label>118</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Agger</surname><given-names>EM</given-names></name><name><surname>Rosenkrands</surname><given-names>I</given-names></name><name><surname>Hansen</surname><given-names>J</given-names></name><name><surname>Brahimi</surname><given-names>K</given-names></name><name><surname>Vandahl</surname><given-names>BS</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements.</article-title>
<source>PLoS ONE</source>
<volume>3</volume>
<fpage>e3116</fpage>
<comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0003116">10.1371/journal.pone.0003116</ext-link></comment>
<pub-id pub-id-type="pmid">18776936</pub-id></element-citation></ref><ref id="ppat.1002607-Ishikawa1"><label>119</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ishikawa</surname><given-names>E</given-names></name><name><surname>Ishikawa</surname><given-names>T</given-names></name><name><surname>Morita</surname><given-names>YS</given-names></name><name><surname>Toyonaga</surname><given-names>K</given-names></name><name><surname>Yamada</surname><given-names>H</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle.</article-title>
<source>J Exp Med</source>
<volume>206</volume>
<fpage>2879</fpage>
<lpage>2888</lpage>
<pub-id pub-id-type="pmid">20008526</pub-id></element-citation></ref><ref id="ppat.1002607-Rouanet1"><label>120</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rouanet</surname><given-names>C</given-names></name><name><surname>Debrie</surname><given-names>AS</given-names></name><name><surname>Lecher</surname><given-names>S</given-names></name><name><surname>Locht</surname><given-names>C</given-names></name></person-group>
<year>2009</year>
<article-title>Subcutaneous boosting with heparin binding haemagglutinin increases BCG-induced protection against tuberculosis.</article-title>
<source>Microbes Infect</source>
<volume>11</volume>
<fpage>995</fpage>
<lpage>1001</lpage>
<pub-id pub-id-type="pmid">19635582</pub-id></element-citation></ref><ref id="ppat.1002607-Locht1"><label>121</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Locht</surname><given-names>C</given-names></name><name><surname>Hougardy</surname><given-names>JM</given-names></name><name><surname>Rouanet</surname><given-names>C</given-names></name><name><surname>Place</surname><given-names>S</given-names></name><name><surname>Mascart</surname><given-names>F</given-names></name></person-group>
<year>2006</year>
<article-title>Heparin-binding hemagglutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis.</article-title>
<source>Tuberculosis (Edinb )</source>
<volume>86</volume>
<fpage>303</fpage>
<lpage>309</lpage>
<pub-id pub-id-type="pmid">16510310</pub-id></element-citation></ref><ref id="ppat.1002607-Pethe1"><label>122</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pethe</surname><given-names>K</given-names></name><name><surname>Alonso</surname><given-names>S</given-names></name><name><surname>Biet</surname><given-names>F</given-names></name><name><surname>Delogu</surname><given-names>G</given-names></name><name><surname>Brennan</surname><given-names>MJ</given-names></name><etal/></person-group>
<year>2001</year>
<article-title>The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination.</article-title>
<source>Nature</source>
<volume>412</volume>
<fpage>190</fpage>
<lpage>194</lpage>
<pub-id pub-id-type="pmid">11449276</pub-id></element-citation></ref><ref id="ppat.1002607-Schnappinger1"><label>123</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schnappinger</surname><given-names>D</given-names></name><name><surname>Ehrt</surname><given-names>S</given-names></name><name><surname>Voskuil</surname><given-names>MI</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Mangan</surname><given-names>JA</given-names></name><etal/></person-group>
<year>2003</year>
<article-title>Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment.</article-title>
<source>J Exp Med</source>
<volume>198</volume>
<fpage>693</fpage>
<lpage>704</lpage>
<pub-id pub-id-type="pmid">12953091</pub-id></element-citation></ref><ref id="ppat.1002607-Leyten1"><label>124</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leyten</surname><given-names>EM</given-names></name><name><surname>Lin</surname><given-names>MY</given-names></name><name><surname>Franken</surname><given-names>KL</given-names></name><name><surname>Friggen</surname><given-names>AH</given-names></name><name><surname>Prins</surname><given-names>C</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis.</article-title>
<source>Microbes Infect</source>
<volume>8</volume>
<fpage>2052</fpage>
<lpage>2060</lpage>
<pub-id pub-id-type="pmid">16931093</pub-id></element-citation></ref><ref id="ppat.1002607-Black1"><label>125</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Black</surname><given-names>GF</given-names></name><name><surname>Thiel</surname><given-names>BA</given-names></name><name><surname>Ota</surname><given-names>MO</given-names></name><name><surname>Parida</surname><given-names>SK</given-names></name><name><surname>Adegbola</surname><given-names>R</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa.</article-title>
<source>Clin Vaccine Immunol</source>
<volume>16</volume>
<fpage>1203</fpage>
<lpage>1212</lpage>
<pub-id pub-id-type="pmid">19553548</pub-id></element-citation></ref><ref id="ppat.1002607-Schuck1"><label>126</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schuck</surname><given-names>SD</given-names></name><name><surname>Mueller</surname><given-names>H</given-names></name><name><surname>Kunitz</surname><given-names>F</given-names></name><name><surname>Neher</surname><given-names>A</given-names></name><name><surname>Hoffmann</surname><given-names>H</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Identification of T-cell antigens specific for latent mycobacterium tuberculosis infection.</article-title>
<source>PLoS ONE</source>
<volume>4</volume>
<fpage>e5590</fpage>
<comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0005590">10.1371/journal.pone.0005590</ext-link></comment>
<pub-id pub-id-type="pmid">19440342</pub-id></element-citation></ref><ref id="ppat.1002607-Lin1"><label>127</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lin</surname><given-names>MY</given-names></name><name><surname>Ottenhoff</surname><given-names>TH</given-names></name></person-group>
<year>2008</year>
<article-title>Not to wake a sleeping giant: new insights into host-pathogen interactions identify new targets for vaccination against latent Mycobacterium tuberculosis infection.</article-title>
<source>Biol Chem</source>
<volume>389</volume>
<fpage>497</fpage>
<lpage>511</lpage>
<pub-id pub-id-type="pmid">18953716</pub-id></element-citation></ref><ref id="ppat.1002607-Lin2"><label>128</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lin</surname><given-names>MY</given-names></name><name><surname>Ottenhoff</surname><given-names>TH</given-names></name></person-group>
<year>2008</year>
<article-title>Host-pathogen interactions in latent Mycobacterium tuberculosis infection: identification of new targets for tuberculosis intervention.</article-title>
<source>Endocr Metab Immune Disord Drug Targets</source>
<volume>8</volume>
<fpage>15</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="pmid">18393920</pub-id></element-citation></ref><ref id="ppat.1002607-Rustad1"><label>129</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rustad</surname><given-names>TR</given-names></name><name><surname>Harrell</surname><given-names>MI</given-names></name><name><surname>Liao</surname><given-names>R</given-names></name><name><surname>Sherman</surname><given-names>DR</given-names></name></person-group>
<year>2008</year>
<article-title>The enduring hypoxic response of Mycobacterium tuberculosis.</article-title>
<source>PLoS ONE</source>
<volume>3</volume>
<fpage>e1502</fpage>
<comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0001502">10.1371/journal.pone.0001502</ext-link></comment>
<pub-id pub-id-type="pmid">18231589</pub-id></element-citation></ref><ref id="ppat.1002607-Aagaard1"><label>130</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aagaard</surname><given-names>C</given-names></name><name><surname>Hoang</surname><given-names>T</given-names></name><name><surname>Dietrich</surname><given-names>J</given-names></name><name><surname>Cardona</surname><given-names>PJ</given-names></name><name><surname>Izzo</surname><given-names>A</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>A multistage tuberculosis vaccine that confers efficient protection before and after exposure.</article-title>
<source>Nat Med</source>
<volume>17</volume>
<fpage>189</fpage>
<lpage>194</lpage>
<pub-id pub-id-type="pmid">21258338</pub-id></element-citation></ref><ref id="ppat.1002607-Govender1"><label>131</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Govender</surname><given-names>L</given-names></name><name><surname>Abel</surname><given-names>B</given-names></name><name><surname>Hughes</surname><given-names>EJ</given-names></name><name><surname>Scriba</surname><given-names>TJ</given-names></name><name><surname>Kagina</surname><given-names>BM</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>Higher human CD4 T cell response to novel Mycobacterium tuberculosis latency associated antigens Rv2660 and Rv2659 in latent infection compared with tuberculosis disease.</article-title>
<source>Vaccine</source>
<volume>29</volume>
<fpage>51</fpage>
<lpage>57</lpage>
<pub-id pub-id-type="pmid">20974305</pub-id></element-citation></ref><ref id="ppat.1002607-Lin3"><label>132</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lin</surname><given-names>PL</given-names></name><name><surname>Dietrich</surname><given-names>J</given-names></name><name><surname>Tan</surname><given-names>E</given-names></name><name><surname>Abalos</surname><given-names>RM</given-names></name><name><surname>Burgos</surname><given-names>J</given-names></name><etal/></person-group>
<year>2012</year>
<article-title>The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection.</article-title>
<source>J Clin Invest</source>
<volume>122</volume>
<fpage>303</fpage>
<lpage>314</lpage>
<pub-id pub-id-type="pmid">22133873</pub-id></element-citation></ref><ref id="ppat.1002607-Wilson1"><label>133</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wilson</surname><given-names>ME</given-names></name><name><surname>Fineberg</surname><given-names>HV</given-names></name><name><surname>Colditz</surname><given-names>GA</given-names></name></person-group>
<year>1995</year>
<article-title>Geographic latitude and the efficacy of bacillus Calmette-Guerin vaccine.</article-title>
<source>Clin Infect Dis</source>
<volume>20</volume>
<fpage>982</fpage>
<lpage>991</lpage>
<pub-id pub-id-type="pmid">7795103</pub-id></element-citation></ref><ref id="ppat.1002607-Liu1"><label>134</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>PT</given-names></name><name><surname>Stenger</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Wenzel</surname><given-names>L</given-names></name><name><surname>Tan</surname><given-names>BH</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response.</article-title>
<source>Science</source>
<volume>311</volume>
<fpage>1770</fpage>
<lpage>1773</lpage>
<pub-id pub-id-type="pmid">16497887</pub-id></element-citation></ref><ref id="ppat.1002607-Fabri1"><label>135</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fabri</surname><given-names>M</given-names></name><name><surname>Stenger</surname><given-names>S</given-names></name><name><surname>Shin</surname><given-names>DM</given-names></name><name><surname>Yuk</surname><given-names>JM</given-names></name><name><surname>Liu</surname><given-names>PT</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages.</article-title>
<source>Sci Transl Med</source>
<volume>3</volume>
<fpage>104ra102</fpage>
</element-citation></ref><ref id="ppat.1002607-Jacobsen1"><label>136</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jacobsen</surname><given-names>M</given-names></name><name><surname>Repsilber</surname><given-names>D</given-names></name><name><surname>Kleinsteuber</surname><given-names>K</given-names></name><name><surname>Gutschmidt</surname><given-names>A</given-names></name><name><surname>Schommer-Leitner</surname><given-names>S</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>Suppressor of cytokine signaling-3 is affected in T-cells from tuberculosisTB patients.</article-title>
<source>Clin Microbiol Infect</source>
<volume>17</volume>
<fpage>1323</fpage>
<lpage>1331</lpage>
<pub-id pub-id-type="pmid">20673263</pub-id></element-citation></ref><ref id="ppat.1002607-Lockhart1"><label>137</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lockhart</surname><given-names>E</given-names></name><name><surname>Green</surname><given-names>AM</given-names></name><name><surname>Flynn</surname><given-names>JL</given-names></name></person-group>
<year>2006</year>
<article-title>IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection.</article-title>
<source>J Immunol</source>
<volume>177</volume>
<fpage>4662</fpage>
<lpage>4669</lpage>
<pub-id pub-id-type="pmid">16982905</pub-id></element-citation></ref><ref id="ppat.1002607-Joosten4"><label>138</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Joosten</surname><given-names>SA</given-names></name><name><surname>Goeman</surname><given-names>JJ</given-names></name><name><surname>Sutherland</surname><given-names>JS</given-names></name><name><surname>Opmeer</surname><given-names>L</given-names></name><name><surname>de Boer</surname><given-names>KG</given-names></name><etal/></person-group>
<year>2012</year>
<article-title>Identification of biomarkers for tuberculosis disease using a novel dual-color RT-MLPA assay.</article-title>
<source>Genes Immun</source>
<volume>13</volume>
<fpage>71</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="pmid">21956656</pub-id></element-citation></ref><ref id="ppat.1002607-Geissmann1"><label>139</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Geissmann</surname><given-names>F</given-names></name><name><surname>Manz</surname><given-names>MG</given-names></name><name><surname>Jung</surname><given-names>S</given-names></name><name><surname>Sieweke</surname><given-names>MH</given-names></name><name><surname>Merad</surname><given-names>M</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>Development of monocytes, macrophages, and dendritic cells.</article-title>
<source>Science</source>
<volume>327</volume>
<fpage>656</fpage>
<lpage>661</lpage>
<pub-id pub-id-type="pmid">20133564</pub-id></element-citation></ref><ref id="ppat.1002607-Schuurhuis1"><label>140</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schuurhuis</surname><given-names>DH</given-names></name><name><surname>van</surname><given-names>MN</given-names></name><name><surname>Ioan-Facsinay</surname><given-names>A</given-names></name><name><surname>Jiawan</surname><given-names>R</given-names></name><name><surname>Camps</surname><given-names>M</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine.</article-title>
<source>J Immunol</source>
<volume>176</volume>
<fpage>4573</fpage>
<lpage>4580</lpage>
<pub-id pub-id-type="pmid">16585547</pub-id></element-citation></ref><ref id="ppat.1002607-GarciaContreras1"><label>141</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Garcia-Contreras</surname><given-names>L</given-names></name><name><surname>Wong</surname><given-names>YL</given-names></name><name><surname>Muttil</surname><given-names>P</given-names></name><name><surname>Padilla</surname><given-names>D</given-names></name><name><surname>Sadoff</surname><given-names>J</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>Immunization by a bacterial aerosol.</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>105</volume>
<fpage>4656</fpage>
<lpage>4660</lpage>
<pub-id pub-id-type="pmid">18344320</pub-id></element-citation></ref><ref id="ppat.1002607-Jeyanathan1"><label>142</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jeyanathan</surname><given-names>M</given-names></name><name><surname>Heriazon</surname><given-names>A</given-names></name><name><surname>Xing</surname><given-names>Z</given-names></name></person-group>
<year>2010</year>
<article-title>Airway luminal T cells: a newcomer on the stage of TB vaccination strategies.</article-title>
<source>Trends Immunol</source>
<volume>31</volume>
<fpage>247</fpage>
<lpage>252</lpage>
<pub-id pub-id-type="pmid">20542470</pub-id></element-citation></ref><ref id="ppat.1002607-Jeyanathan2"><label>143</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jeyanathan</surname><given-names>M</given-names></name><name><surname>Mu</surname><given-names>J</given-names></name><name><surname>McCormick</surname><given-names>S</given-names></name><name><surname>Damjanovic</surname><given-names>D</given-names></name><name><surname>Small</surname><given-names>CL</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>Murine airway luminal antituberculosis memory CD8 T cells by mucosal immunization are maintained via antigen-driven in situ proliferation, independent of peripheral T cell recruitment.</article-title>
<source>Am J Respir Crit Care Med</source>
<volume>181</volume>
<fpage>862</fpage>
<lpage>872</lpage>
<pub-id pub-id-type="pmid">20019338</pub-id></element-citation></ref><ref id="ppat.1002607-Tchilian1"><label>144</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tchilian</surname><given-names>EZ</given-names></name><name><surname>Ronan</surname><given-names>EO</given-names></name><name><surname>de Lara</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>LN</given-names></name><name><surname>Franken</surname><given-names>KL</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>Simultaneous immunization against tuberculosis.</article-title>
<source>PLoS ONE</source>
<volume>6</volume>
<fpage>e27477</fpage>
<comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0027477">10.1371/journal.pone.0027477</ext-link></comment>
<pub-id pub-id-type="pmid">22110657</pub-id></element-citation></ref><ref id="ppat.1002607-Lee2"><label>145</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>LN</given-names></name><name><surname>Ronan</surname><given-names>EO</given-names></name><name><surname>de</surname><given-names>LC</given-names></name><name><surname>Franken</surname><given-names>KL</given-names></name><name><surname>Ottenhoff</surname><given-names>TH</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosis.</article-title>
<source>Infect Immun</source>
<volume>79</volume>
<fpage>3328</fpage>
<lpage>3337</lpage>
<pub-id pub-id-type="pmid">21628524</pub-id></element-citation></ref></